BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24215456)

  • 1. Isothermally sensitive detection of serum circulating miRNAs for lung cancer diagnosis.
    Li Y; Liang L; Zhang CY
    Anal Chem; 2013 Dec; 85(23):11174-9. PubMed ID: 24215456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
    Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
    Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Ultrasensitive Diagnostic Biochip Based on Biomimetic Periodic Nanostructure-Assisted Rolling Circle Amplification.
    Yao Q; Wang Y; Wang J; Chen S; Liu H; Jiang Z; Zhang X; Liu S; Yuan Q; Zhou X
    ACS Nano; 2018 Jul; 12(7):6777-6783. PubMed ID: 29924598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
    Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A
    Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
    Wang RJ; Zheng YH; Wang P; Zhang JZ
    Int J Clin Exp Pathol; 2015; 8(1):765-71. PubMed ID: 25755772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of miR-125a-5p and let-7e predicts the progression and prognosis of non-small cell lung cancer.
    Zhu WY; Luo B; An JY; He JY; Chen DD; Xu LY; Huang YY; Liu XG; Le HB; Zhang YK
    Cancer Invest; 2014 Oct; 32(8):394-401. PubMed ID: 24945821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
    Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y
    Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of serum miRNAs with Cyfra21-1 for the diagnosis of non-small cell lung cancer.
    Zhou C; Chen Z; Dong J; Li J; Shi X; Sun N; Luo M; Zhou F; Tan F; He J
    Cancer Lett; 2015 Oct; 367(2):138-46. PubMed ID: 26213369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
    Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
    Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a Quencher-Free Cascade Amplification System for Highly Specific and Sensitive Detection of Serum Circulating miRNAs.
    Wang LJ; Ren M; Wang HX; Qiu JG; Jiang B; Zhang CY
    Anal Chem; 2020 Jun; 92(12):8546-8552. PubMed ID: 32394711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
    Sher YP; Shih JY; Yang PC; Roffler SR; Chu YW; Wu CW; Yu CL; Peck K
    Clin Cancer Res; 2005 Jan; 11(1):173-9. PubMed ID: 15671543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma.
    Gao W; Liu L; Lu X; Shu Y
    Clin Lung Cancer; 2011 Jan; 12(1):14-7. PubMed ID: 21273174
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel molecular beacons to monitor microRNAs in non-small-cell lung cancer.
    Yao Q; Zhang AM; Ma H; Lin S; Wang XX; Sun JG; Chen ZT
    Mol Cell Probes; 2012 Oct; 26(5):182-7. PubMed ID: 22796123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.
    Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M
    Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer.
    Li ZH; Zhang H; Yang ZG; Wen GQ; Cui YB; Shao GG
    J Int Med Res; 2013 Oct; 41(5):1437-44. PubMed ID: 24065453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface-enhanced Raman spectroscopy for simultaneous sensitive detection of multiple microRNAs in lung cancer cells.
    Ye LP; Hu J; Liang L; Zhang CY
    Chem Commun (Camb); 2014 Oct; 50(80):11883-6. PubMed ID: 25154520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
    Wang ZX; Bian HB; Wang JR; Cheng ZX; Wang KM; De W
    J Surg Oncol; 2011 Dec; 104(7):847-51. PubMed ID: 21721011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon nanotube enhanced label-free detection of microRNAs based on hairpin probe triggered solid-phase rolling-circle amplification.
    Tian Q; Wang Y; Deng R; Lin L; Liu Y; Li J
    Nanoscale; 2015 Jan; 7(3):987-93. PubMed ID: 25470558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
    Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
    Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Serum 4-microRNA Signature for Lung Cancer Detection.
    Nadal E; Truini A; Nakata A; Lin J; Reddy RM; Chang AC; Ramnath N; Gotoh N; Beer DG; Chen G
    Sci Rep; 2015 Jul; 5():12464. PubMed ID: 26202143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.